Abiomed Announces 5-Year, $16+ mln Impella and AB5000 Distribution Agreement with Medix Japan
14th Nov 2006, 13:58 GMT
Abiomed announced a 5-year distribution agreement with Medix Japan Medix intends to initiate clinical trials in Japan during Abiomed's FYE 2008.
Abiomed Announces 5-Year, $16+ mln Impella and AB5000 Distribution Agreement with Medix Japan related news:
- Abiomed, Medix Japan in Distribution Pact — Distribution/ Logistics News from StratCenter.com
- AbioMed wins $16M Japanese distribution deal — bizjournals.com Health Care:Industry Regulation headlines
- Abiomed signs Japanese distribution deal — Latest news from Boston Business Journal
- MediPurpose Announces Exclusive Distribution Agreement for Sangofer Blood Separation Product — Government/ Industry Regulation News from StratCenter.com
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin — ArriveNet : Health
- Clinical Data and Diagene in Cardiac Channelopathy Test Distribution Agreement for Germany, Switzerland and Austria — Cardiology News from StratCenter.com
- Eugene Science Signs Major Distribution Agreement With RexGene Biotech — ArriveNet : Press Releases
- Perceptron Announces Q1 Results for FYE 2007 and Receipt of 1st Order for Commercial Products — StratWire - Business of Healthcare NewsFeed
- China Medical Technologies Announces Proposed Offering of $100 mln Convertible Senior Subordinated Notes — Financial News News from StratCenter.com
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares — Operations-Related News from StratCenter.com
Latest news from Distribution/ Logistics News from StratCenter.com:
- Abiomed signs Japanese distribution deal
- Abiomed, Medix Japan in Distribution Pact
- Flu Vaccine Distributors Support Nat'l Influenza Vaccination Week
- Federal Court Hears Arguments Against Controversial DM&E Railroad Project
- Langer acquires Twincraft
- Cardinal Health Releases RFID Pilot Results
- Natrol Announces Q3 2006 Results
- Medical Services Receives Regulatory Approval in Saudi Arabia
- Interpharm Announces Record Revenues and Profits for the 3 Month Period Ended 9/30/2006
- China Biopharmaceuticals Holdings Announces Q3 Results